{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:39:37Z","timestamp":1793813977342,"version":"4.6.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Science","doi-asserted-by":"crossref","award":["CTSA UL1 TR000142"],"award-info":[{"award-number":["CTSA UL1 TR000142"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,9,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Michiaki Takahashi developed the live attenuated varicella vaccine in 1974 . This was the first, and is still the only, herpesvirus vaccine. Early studies showed promise, but the vaccine was rigorously tested on immunosuppressed patients because of their high risk of fatal varicella; vaccination proved to be lifesaving. Subsequently, the vaccine was found to be safe and effective in healthy children. Eventually, varicella vaccine became a component of measles mumps rubella vaccine, 2 doses of which are administered in the USA to ~90% of children. The incidence of varicella has dropped dramatically in the USA since vaccine-licensure in 1995. Varicella vaccine is also associated with a decreased incidence of zoster and is protective for susceptible adults. Today, immunocompromised individuals are protected against varicella due to vaccine-induced herd immunity. Latent infection with varicella zoster virus occurs after vaccination; however, the vaccine strain is impaired for its ability to reactivate.<\/jats:p>","DOI":"10.1093\/infdis\/jiaa573","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T15:13:24Z","timestamp":1599491604000},"page":"S387-S397","source":"Crossref","is-referenced-by-count":81,"title":["Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster"],"prefix":"10.1093","volume":"224","author":[{"given":"Anne A","family":"Gershon","sequence":"first","affiliation":[{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Gershon","sequence":"additional","affiliation":[{"name":"Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene D","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, New Haven, Connecticut, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"2021093008010589800_CIT0001","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/cid\/civ320","article-title":"Use of saliva to identify varicella zoster virus infection of the gut","volume":"61","author":"Gershon","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021093008010589800_CIT0002","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM196208232670801","article-title":"Modification of chicken pox in family contacts by administration of gamma globulin","volume":"267","author":"Ross","year":"1962","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0003","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1056\/NEJM196905292802201","article-title":"Prevention of varicella by zoster immune globulin","volume":"280","author":"Brunell","year":"1969","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0004","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM197401312900503","article-title":"Zoster immune globulin. A further assessment","volume":"290","author":"Gershon","year":"1974","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0005","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1542\/peds.80.4.465","article-title":"Varicella in children with cancer: impact of antiviral therapy and prophylaxis","volume":"80","author":"Feldman","year":"1987","journal-title":"Pediatrics"},{"key":"2021093008010589800_CIT0006","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0140-6736(74)90144-5","article-title":"Live vaccine used to prevent the spread of varicella in children in hospital","volume":"2","author":"Takahashi","year":"1974","journal-title":"Lancet"},{"key":"2021093008010589800_CIT0007","first-page":"25","article-title":"Development of a live attenuated varicella vaccine","volume":"18","author":"Takahashi","year":"1975","journal-title":"Biken J"},{"key":"2021093008010589800_CIT0008","first-page":"1535","article-title":"Development of live varicella vaccine","volume":"43","author":"Takahashi","year":"1985","journal-title":"Nihon Rinsho"},{"key":"2021093008010589800_CIT0009","first-page":"61","article-title":"Clinical experience with Oka live varicella vaccine in Japan","volume":"61","author":"Takahashi","year":"1985","journal-title":"Postgrad Med J"},{"key":"2021093008010589800_CIT0010","first-page":"249","article-title":"Varicella vaccine: case studies","volume":"2","author":"Takahashi","year":"1985","journal-title":"Microbiol. Sci"},{"key":"2021093008010589800_CIT0011","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1542\/peds.78.4.736","article-title":"Clinical overview of varicella vaccine: development and early studies","volume":"78","author":"Takahashi","year":"1986","journal-title":"Pediatrics"},{"key":"2021093008010589800_CIT0012","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0891-5520(05)70309-3","article-title":"The varicella vaccine. Vaccine development","volume":"10","author":"Takahashi","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"2021093008010589800_CIT0013","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/jama.1984.03350030023016","article-title":"Live attenuated varicella vaccine: efficacy for children with leukemia in remission","volume":"252","author":"Gershon","year":"1984","journal-title":"JAMA"},{"key":"2021093008010589800_CIT0014","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM199111283252204","article-title":"The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group","volume":"325","author":"Hardy","year":"1991","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0015","first-page":"1145","article-title":"Live attenuated varicella vaccine.","volume-title":"Vaccines","author":"Gershon","year":"2018"},{"key":"2021093008010589800_CIT0016","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0891-5520(05)70315-9","article-title":"Clinical trials of varicella vaccine in healthy children","volume":"10","author":"White","year":"1996","journal-title":"Infect Dis Clin North Am"},{"key":"2021093008010589800_CIT0017","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/infdis\/172.3.706","article-title":"The epidemiology of varicella and its complications","volume":"172","author":"Choo","year":"1995","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0018","first-page":"311","article-title":"Comparisons between chickenpox in a tropical and a European country","volume":"66","author":"Maretic","year":"1963","journal-title":"J Trop Med Hyg"},{"key":"2021093008010589800_CIT0019","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/nrdp.2015.16","article-title":"Varicella zoster virus infection","volume":"1","author":"Gershon","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2021093008010589800_CIT0020","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1086\/527421","article-title":"Herpes zoster: new insights provide an important wake-up call for management of nosocomial transmission","volume":"197","author":"Breuer","year":"2008","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0021","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/B978-1-4160-3611-1.50041-6","article-title":"Zoster vaccine","volume-title":"Vaccines","author":"Levin","year":"2008"},{"key":"2021093008010589800_CIT0022","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1128\/CMR.00052-13","article-title":"Pathogenesis and current approaches to control of varicella-zoster virus infections","volume":"26","author":"Gershon","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"2021093008010589800_CIT0023","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJM198405313102201","article-title":"Live attenuated varicella virus vaccine. Efficacy trial in healthy children","volume":"310","author":"Weibel","year":"1984","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0024","doi-asserted-by":"crossref","first-page":"S330","DOI":"10.1093\/infdis\/174.Supplement_3.S330","article-title":"Efficacy of high-titer live attenuated varicella vaccine in healthy young children","volume":"174","author":"Varis","year":"1996","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/infdis\/158.1.132","article-title":"Immunization of healthy adults with live attenuated varicella vaccine","volume":"158","author":"Gershon","year":"1988","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0026","first-page":"17","article-title":"A benefit-cost analysis of a childhood varicella vaccination programme","volume":"61","author":"Preblud","year":"1985","journal-title":"Postgrad Med J"},{"key":"2021093008010589800_CIT0027","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.1994.03510290057037","article-title":"Cost-effectiveness of a routine varicella vaccination program for US children","volume":"271","author":"Lieu","year":"1994","journal-title":"JAMA"},{"key":"2021093008010589800_CIT0028","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine","volume":"291","author":"V\u00e1zquez","year":"2004","journal-title":"JAMA"},{"key":"2021093008010589800_CIT0029","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/infdis\/jiq052","article-title":"Effectiveness of 2 doses of varicella vaccine in children","volume":"203","author":"Shapiro","year":"2011","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0030","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"56","author":"Marin","year":"2007","journal-title":"MMWR Recomm Rep"},{"key":"2021093008010589800_CIT0031","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: a 10\u202fyear review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"2021093008010589800_CIT0032","first-page":"359","article-title":"Perspectives on vaccines against varicella-zoster virus infections","volume":"342","author":"Gershon","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"2021093008010589800_CIT0033","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0140-6736(07)60567-4","article-title":"Varicella vaccination in a child with acute lymphoblastic leukaemia","volume":"369","author":"Schrauder","year":"2007","journal-title":"Lancet"},{"key":"2021093008010589800_CIT0034","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciu970","article-title":"Disseminated, persistent, and fatal infection due to the vaccine strain of varicella-zoster virus in an adult following stem cell transplantation","volume":"60","author":"Bhalla","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2021093008010589800_CIT0035","doi-asserted-by":"crossref","first-page":"bcr2015212688","DOI":"10.1136\/bcr-2015-212688","article-title":"Fatal disseminated varicella zoster infection following zoster vaccination in an immunocompromised patient","volume":"2016","author":"Costa","year":"2016","journal-title":"BMJ Case Rep"},{"key":"2021093008010589800_CIT0036","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4161\/hv.26200","article-title":"Fatal varicella due to the vaccine-strain varicella-zoster virus","volume":"10","author":"Leung","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2021093008010589800_CIT0037","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1016\/j.vaccine.2018.05.078","article-title":"Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection","volume":"36","author":"Alexander","year":"2018","journal-title":"Vaccine"},{"key":"2021093008010589800_CIT0038","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s10875-015-0207-8","article-title":"Late onset hypomorphic RAG2 deficiency presentation with fatal vaccine-strain VZV infection","volume":"35","author":"Dutmer","year":"2015","journal-title":"J Clin Immunol"},{"key":"2021093008010589800_CIT0039","doi-asserted-by":"crossref","first-page":"e20191522","DOI":"10.1542\/peds.2019-1522","article-title":"Vaccine Oka varicella meningitis in two adolescents","volume":"144","author":"Harrington","year":"2019","journal-title":"Pediatrics"},{"key":"2021093008010589800_CIT0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0022-3476(05)82872-0","article-title":"Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus","volume":"116","author":"Tsolia","year":"1990","journal-title":"J Pediatr"},{"key":"2021093008010589800_CIT0041","doi-asserted-by":"crossref","first-page":"e20191305","DOI":"10.1542\/peds.2019-1305","article-title":"Transmission of vaccine-strain varicella-zoster virus: a systematic review","volume":"144","author":"Marin","year":"2019","journal-title":"Pediatrics"},{"key":"2021093008010589800_CIT0042","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.292.6.704","article-title":"Contagiousness of varicella in vaccinated cases: a household contact study","volume":"292","author":"Seward","year":"2004","journal-title":"JAMA"},{"key":"2021093008010589800_CIT0043","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1056\/NEJM196601272740403","article-title":"Serologic and virus-isolation studies of patients with varicella or herpes-zoster infection","volume":"274","author":"Gold","year":"1966","journal-title":"N Engl J Med"},{"key":"2021093008010589800_CIT0044","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/14760584.2017.1294069","article-title":"Severe varicella in persons vaccinated with varicella vaccine (breakthrough varicella): a systematic literature review","volume":"16","author":"Leung","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"2021093008010589800_CIT0045","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/infdis\/jit405","article-title":"Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009","volume":"208","author":"Weinmann","year":"2013","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0046","doi-asserted-by":"crossref","first-page":"e20182917","DOI":"10.1542\/peds.2018-2917","article-title":"Incidence of herpes zoster among children: 2003\u20132014","volume":"144","author":"Weinmann","year":"2019","journal-title":"Pediatrics"},{"key":"2021093008010589800_CIT0047","doi-asserted-by":"crossref","first-page":"E2403","DOI":"10.1073\/pnas.1522575113","article-title":"In vitro system using human neurons demonstrates that varicella-zoster vaccine virus is impaired for reactivation, but not latency","volume":"113","author":"Sadaoka","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021093008010589800_CIT0048","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/S0264-410X(02)00180-9","article-title":"Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"2021093008010589800_CIT0049","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1093\/infdis\/173.2.450","article-title":"The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox","volume":"173","author":"Gershon","year":"1996","journal-title":"J Infect Dis"},{"key":"2021093008010589800_CIT0050","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev Vaccines"},{"key":"2021093008010589800_CIT0051","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/cid\/cir436","article-title":"Does monastic life predispose to the risk of Saint Anthony\u2019s fire (herpes zoster)?","volume":"53","author":"Gaillat","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2021093008010589800_CIT0052","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/003591576505800106","article-title":"The nature of herpes zoster: a long term study and a new hypothesis","volume":"58","author":"Hope-Simpson","year":"1965","journal-title":"Proc Roy Soc Med"},{"key":"2021093008010589800_CIT0053","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/jmv.10555","article-title":"Stress-induced subclinical reactivation of varicella zoster virus in astronauts","volume":"72","author":"Mehta","year":"2004","journal-title":"J Med Virol"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_4\/S387\/40481527\/jiaa573.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/224\/Supplement_4\/S387\/40481527\/jiaa573.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T22:55:52Z","timestamp":1668639352000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/224\/Supplement_4\/S387\/6378094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":53,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2021,9,30]]},"published-print":{"date-parts":[[2021,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaa573","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,9,30]]}}}